Guardant's blood-based cancer test moves closer to Medicare coverage with FDA approval - Reuters
- Guardant's blood-based cancer test moves closer to Medicare coverage with FDA approval Reuters
- F.D.A. Approves Blood Test for Colon Cancer Detection The New York Times
- Guardant Health’s stock up as FDA approves blood test for colon-cancer screening MarketWatch
- FDA approves blood test for colorectal cancer Axios